News & Insights

IRS Releases Guidance on Changes to R&E Expensing

Facebook Twitter LinkedIn Email

Among its numerous tax provisions, the One Big Beautiful Bill Act (OBBBA) reinstated immediate deductions for research and experimental (R&E) expenditures under Internal Revenue Code Section 174, beginning in 2025. The […]

READ MORE

Is Your Company’s Pricing Strategy Still Viable?

Facebook Twitter LinkedIn Email

Pricing is among the most powerful levers for business owners to calibrate their companies’ profitability. Set prices too low and you risk leaving money on the table. Set them too […]

READ MORE

The Payroll Implications of the One Big Beautiful Bill Act: What We Currently Know

Facebook Twitter LinkedIn Email

The One Big Beautiful Bill Act (OBBBA), signed into law on July 4, 2025, has impacted many areas of taxation, including individual, business, and payroll taxes. As of September 2025, […]

READ MORE

Delisting Decisions: The Complex Road to Going Private

Facebook Twitter LinkedIn Email

U.S. public companies may decide to delist — or “go private” — for various strategic and financial reasons. For example, chain retailer Walgreens recently finalized a private equity deal worth […]

READ MORE

New Rules Could Boost Your R&E Tax Savings in 2025

Facebook Twitter LinkedIn Email

A major tax change is here for businesses with research and experimental (R&E) expenses. On July 4, 2025, the One Big Beautiful Bill Act (OBBBA) reinstated the immediate deduction for U.S.-based […]

READ MORE

Recent Posts